Found 16 matching trials
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
PHASE1PART 1:
1. To explore the safety of ZG005 in combination with Gecacitinib ...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
PHASE1This is a multicenter, open-label phase I/II study in patients with advance...
Location
Zhejiang Cancer Hospital
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
NAThis open-label, non-randomized, phase II exploratory study aims to evaluat...
Location
Blood diseases hospital
A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV
NAThe goal of this clinical trial is to evaluate the efficacy and safety of G...
Location
Peking Union Medical College Hospital
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
PHASE2The purpose of this study is to evaluate the safety and efficacy of Gecacit...
Location
Tianjin Medical University Cancer Institute and Hospital
Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).
PHASE1This study aims to evaluate the safety and efficacy of Gecacitinib in patie...
Location
Multiple Locations
Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels
N/AThis study was an observational study, and about 40 patients with intermedi...
Status
Active Not Recruiting
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
PHASE1This is a multicenter Phase I/II study for patients with advanced non-small...
Location
Shanghai Chest Hospital
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
PHASE1This is a multicenter, open-label phase I/II study for participants with ad...
Location
Chinese PLA General Hosptial
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
PHASE1Chronic Graft-versus-Host Disease (cGVHD) is a common late complication fol...
Location
Peking University First Hospital